… Here, we show that PS-liposomes can be adapted to other autoimmune … liposomes without
PS are being used to deliver anti-inflammatory drugs to control autoimmune inflammation …

… in inflammation can provide a means to effectively control their … , such as those found in
autoimmune diseases.Table 1.. … LNPs) and liposomes are established drug delivery vehicles with …

… Autoimmune disease is a chronic inflammatory disease … While the activation status of the
DCs controls the induction … corticosteroids, the liposomal drug delivery system effectively …

… Our results provide evidence for neuroinflammation and … Littermate controls (liposome or
saline) of both sexes were … may be of value to study fulminant brain inflammation, we are not yet …

… and adults will help to prevent and treat infection, and control inflammation and damage. …
type 1 interferon pathway is associated with autoimmune/inflammatory conditions, such as SLE, …

… The nanoparticles achieved controlled release of RNase A upon exposure to oxidative …
nanocarriers for the treatment of autoimmune disease and inflammatory conditions. First, we will …

… [ 32, 33 ] In models of autoimmunity, delivering these drugs … loaded into liposomes that
provide controlled release of drug … T cells—during active autoimmune inflammation, the authors …

… approaches to autoimmune diseases have involved the management of symptomatic … of
inflammatory arthritis, Capini and colleagues showed that an injection of liposomes loaded with …

… ) and IL-1 can promote inflammation and/or autoimmune disorders. … controlled for potential
therapeutic benefit, including by cytokine engineering. IL-2 was approved by the FDA for use …

… Intestinal permeability and bioavailability of salmon calcitonin liposomes … modulation by
the carrier material itself offers significant therapeutic control over pancreatic inflammation …